ReleaseWire

GlobalData's clinical trial report, "Malignant Mesothelioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Mesothelioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Mesothelioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Mesothelioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasopharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nasopharyngeal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014" provides data on the Germinomatous (Seminomatous) Germ Cell Tumors clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Germinomatous (Seminomatous) Germ Cell Tumors. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Germinomatous (Seminomatous) Germ Cell Tumors. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Leiomyosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Leiomyosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leiomyosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leiomyosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014', provides an overview of the Arromax Pharmatech, Co. Ltd.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Scabies Global Clinical Trials Review, H1, 2014" provides data on the Scabies clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Scabies. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Scabies. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Low-Grade Glioma Global Clinical Trials Review, H1, 2014" provides data on the Low-Grade Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Low-Grade Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Low-Grade Glioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014', provides an overview of the Gastrointestinal Stromal Tumor (GIST)'s therapeutic pipeline.

Global Markets Direct's, 'Systemic Lupus Erythematosus - Pipeline Review, H1 2014', provides an overview of the Systemic Lupus Erythematosus's therapeutic pipeline.

Global Markets Direct's, 'Chronic Heart Failure - Pipeline Review, H1 2014', provides an overview of the Chronic Heart Failure's therapeutic pipeline.

Global Markets Direct's, 'Vectura Group plc - Product Pipeline Review - 2014', provides an overview of the Vectura Group plc's pharmaceutical research and development focus.

Global Markets Direct's, 'Chronos Therapeutics Limited - Product Pipeline Review - 2014', provides an overview of the Chronos Therapeutics Limited's pharmaceutical research and development focus.

Global Markets Direct's, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014', provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)'s therapeutic pipeline.

Global Markets Direct's, 'Metastatic Colorectal Cancer - Pipeline Review, H1 2014', provides an overview of the Metastatic Colorectal Cancer's therapeutic pipeline.

Global Markets Direct's, 'Hypertension - Pipeline Review, H1 2014', provides an overview of the Hypertension's therapeutic pipeline.

Global Markets Direct's, 'Liver Failure - Pipeline Review, H1 2014', provides an overview of the Liver Failure's therapeutic pipeline.

Global Markets Direct's, 'Osteoporosis - Pipeline Review, H1 2014', provides an overview of the Osteoporosis's therapeutic pipeline.

GlobalData's clinical trial report, "Mast Cell Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Mast Cell Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mast Cell Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mast Cell Leukemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Huntington's Disease - Pipeline Review, H1 2014', provides an overview of the Huntington's Disease's therapeutic pipeline.

Global Markets Direct's, 'Angina (Angina Pectoris) - Pipeline Review, H1 2014', provides an overview of the Angina (Angina Pectoris)'s therapeutic pipeline.

Global Markets Direct's, 'Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014', provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL)'s therapeutic pipeline.

Global Markets Direct's, 'Follicular Lymphoma - Pipeline Review, H1 2014', provides an overview of the Follicular Lymphoma's therapeutic pipeline.

Global Markets Direct's, 'Acute Pain - Pipeline Review, H1 2014', provides an overview of the Acute Pain's therapeutic pipeline.

Global Markets Direct's, 'Invion Limited - Product Pipeline Review - 2014', provides an overview of the Invion Limited's pharmaceutical research and development focus.

Global Markets Direct's, 'Rheumatoid Arthritis - Pipeline Review, H1 2014', provides an overview of the Rheumatoid Arthritis's therapeutic pipeline.